Your browser doesn't support javascript.
loading
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.
Shields, Adrian M; Tadros, Susan; Al-Hakim, Adam; Nell, Jeremy M; Lin, Me Me Nay; Chan, Michele; Goddard, Sarah; Dempster, John; Dziadzio, Magdalena; Patel, Smita Y; Elkalifa, Shuayb; Huissoon, Aarnoud; Duncan, Christopher J A; Herwadkar, Archana; Khan, Sujoy; Bethune, Claire; Elcombe, Suzanne; Thaventhiran, James; Klenerman, Paul; Lowe, David M; Savic, Sinisa; Burns, Siobhan O; Richter, Alex G.
Afiliação
  • Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Tadros S; Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom.
  • Al-Hakim A; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Nell JM; Department of Allergy and Clinical Immunology, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, United Kingdom.
  • Lin MMN; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Chan M; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Goddard S; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Dempster J; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, United Kingdom.
  • Dziadzio M; Department of Clinical Immunology, University College London Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Patel SY; Department of Clinical Immunology, University College London Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Elkalifa S; National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Oxford Biomedical Centre, University of Oxford, Oxford, United Kingdom.
  • Huissoon A; Department of Clinical Immunology, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.
  • Duncan CJA; Department of Immunology, Salford Royal National Health Service (NHS) Foundation Trust, Salford, United Kingdom.
  • Herwadkar A; Department of Clinical Immunology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom.
  • Khan S; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Bethune C; Department of Immunology, Salford Royal National Health Service (NHS) Foundation Trust, Salford, United Kingdom.
  • Elcombe S; Department of Clinical Immunology, Hull University Teaching Hospitals National Health Service (NHS) Trust, Hull, United Kingdom.
  • Thaventhiran J; Department of Allergy and Clinical Immunology, University Hospitals Plymouth National Health Service (NHS) Trust, Plymouth, United Kingdom.
  • Klenerman P; Department of Allergy and Clinical Immunology, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, Newcastle, United Kingdom.
  • Lowe DM; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Savic S; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Burns SO; Department of Immunology, Royal Free London National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Richter AG; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
Front Immunol ; 13: 984376, 2022.
Article em En | MEDLINE | ID: mdl-36211396
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_medicamentos_vacinas_tecnologias / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_medicamentos_vacinas_tecnologias / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido